^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
GALEAS Tumor

Company:
Nonacus
Type:
Laboratory Developed Test
Related tests:

Details

Evidence
News
GALEAS Tumor is an expertly curated NGS panel developed in parallel with bioinformatics pipelines for the comprehensive profiling of solid tumors. It targets 519 carefully selected, clinically relevant genes aligned with the UK NHS national genomic test directory, NCCN, FDA and ESMO guidelines.
Gene:
HRD (Homologous Recombination Deficiency), MSI (Microsatellite instability), TMB (Tumor Mutational Burden)
Method:
Next-generation sequencing